Earnings Insights · AEHR · Q1 FY2027

Aehr Test Systems Q1 FY2027 Earnings: Record Revenue Drives Higher $150M Outlook

By AlgovestIQ ResearchPublished

Share

Read Aehr Test Systems’s results announcement (Form 8-K, filed Nov 2, 2026)

Key earnings findings

Aehr Test Systems (AEHR) Q1 FY2027 · results discussed on the earnings call · Form 8-K filed

  1. Aehr Test Systems reported Q1 FY2027 revenue of $33.0M against the $27.6M analyst estimate, a 19.4% beat, and EPS of $0.28 against the $0.12 analyst estimate.
  2. The quarter reflected a sharp ramp in AI-related wafer-level and package-level burn-in programs, while bookings of $46.7M exceeded revenue and supported an increase in full-year revenue guidance to $150M.
  3. AEHR closed at $65.11 on Nov 3, 2026, up 26.5% from $51.47 on Nov 2, 2026, the last close before the results were released.

Sources: Aehr Test Systems results announcement (SEC), the Q1 FY2027 earnings call, and AlgovestIQ reported-results and market data. All references

Did Aehr Test Systems beat earnings expectations?

Actual
Estimate
Surprise
Revenue
$33.0M
$27.6M
+19.4%
EPS
$0.28
$0.12
+139.9%
  • EPS has beaten the estimate in 4 of the most recent reported quarters.
  • Revenue surprise across the last 8 reported quarters has ranged from -31.6% to 23.5%.

Reported figures against analyst estimates, compiled from AlgovestIQ data.

Aehr Test Systems opened fiscal 2027 with record revenue of $33.0M, up 200% from the comparable prior-year period, and GAAP diluted EPS of $0.21 versus a $0.07 loss a year earlier. The quarter reflected a sharp ramp in AI-related wafer-level and package-level burn-in programs, while bookings of $46.7M exceeded revenue and supported an increase in full-year revenue guidance to $150M.

The central development is that Aehr is moving from qualification programs toward larger production deployments, particularly with AI processor customers. That transition is improving revenue scale and profitability, but a meaningful part of the longer-term opportunity still depends on customer production ramps and a major wafer-level burn-in evaluation scheduled to begin in Taiwan in early calendar 2027.

Earnings Snapshot

MetricReportedChange
Revenue$33.0MUp 200% year over year; up 75% sequentially
GAAP gross margin47.5%—
Non-GAAP gross margin48.5%Up from 37.5%
GAAP operating income$6.0MVersus $(4.1)M loss
GAAP net income$7.2MVersus $(2.1)M loss
GAAP diluted EPS$0.21Versus $(0.07) loss
Non-GAAP net income$9.4MVersus $0.2M
Non-GAAP diluted EPS$0.28Versus $0.01
Bookings$46.7MUp more than 300%
Book-to-bill ratio1.4Bookings exceeded revenue
Quarter-end backlog$100.9MUp from $80.6M at fiscal 2026 year-end
Effective backlog$109.3MIncludes $8.4M of post-quarter bookings
Consumables and related revenue$13.5M41% of revenue, versus 24% a year earlier
Cash, cash equivalents and restricted cash$105.1MDown from $116.5M at fiscal 2026 year-end
Operating cash flow$(3.1)MWorking-capital use

The Bigger Story

Aehr’s quarterly results show the operating leverage possible if its AI-related burn-in systems move into sustained production use. Revenue tripled year over year while non-GAAP operating expenses increased 36%, allowing the company to move from a GAAP operating loss in the comparable period to $6.0M of operating income.

The more important issue is the breadth of the production pipeline. Management said more than a dozen customers now have the potential to generate meaningful production orders across AI processors, silicon photonics, silicon carbide, gallium nitride and other applications. That is a material change from Aehr’s historically concentrated customer base, although individual customer ramps can still create substantial quarterly volatility.

Aehr is also expanding capacity before all prospective programs are fully converted. Its Southeast Asian contract manufacturing operation can add capacity for more than 20 Sonoma package-level burn-in systems per month, while the company is shifting more subassembly work to suppliers to increase throughput for wafer-level systems.

Revenue and Operating Performance

Revenue reached $33.0M, driven by shipments across both of Aehr’s primary platforms. The company shipped Sonoma package-level burn-in systems to a Taiwan-based outsourced semiconductor assembly and test partner serving its lead hyperscale customer. It also shipped FOX-P systems, including a FOX-XP system and WaferPak auto aligners, to its lead AI processor customer, along with FOX-NP systems for power-semiconductor customers.

Consumables and related products produced $13.5M of revenue, or 41% of the quarter’s total. This category includes WaferPak contactors for wafer-level burn-in and burn-in modules and boards for package-level applications. The fivefold increase from $2.6M a year earlier suggests that revenue growth was not solely dependent on new system sales. These products are tied to installed capacity and new device introductions, though management cautioned that mix can vary materially by quarter.

Management expects consumables to represent roughly 35% of fiscal 2027 revenue, compared with 29% in fiscal 2026. That would support a more recurring component of sales as the installed base grows, but the business remains dependent on customer device volumes, qualification schedules and replacement cycles.

The company’s lead hyperscale customer is currently receiving and installing more than a dozen Sonoma systems per month for its first AI processor. That same customer has qualified a second processor on Sonoma and placed follow-on orders for initial production sampling. Management said the customer expects the second processor to ultimately reach higher production volumes than the first, with a production ramp anticipated during calendar 2027.

Profitability and Margins

GAAP gross margin was 47.5%, while non-GAAP gross margin was 48.5%, up 11 percentage points from 37.5% in the comparable prior-year quarter. Management attributed the gain primarily to higher volume and improved product mix. The prior-year period included a greater share of lower-margin third-party probers and an automated aligner upgrade sold within complete solutions.

GAAP operating income was $6.0M, compared with a $4.1M operating loss in the comparable period. Non-GAAP operating income was $8.2M, compared with a $1.8M loss a year earlier.

GAAP net income was $7.2M, or $0.21 per diluted share. Non-GAAP net income, excluding stock-based compensation and acquisition-related adjustments, was $9.4M, or $0.28 per diluted share. The GAAP result also benefited from a $0.3M income tax benefit, primarily related to discrete items associated with employee equity compensation.

Management expects gross margin for fiscal 2027 to remain around the first-quarter level, with quarter-to-quarter variation based on product mix. It specifically indicated that the second quarter may have a lower gross margin because of a larger mix of Sonoma system shipments.

Demand, Customers and Pricing

Bookings totaled $46.7M, producing a 1.4 book-to-bill ratio and lifting quarter-end backlog to $100.9M despite $33.0M of revenue recognized during the quarter. Including $8.4M of orders received after the quarter ended, effective backlog was $109.3M as of November 1.

The largest unconverted opportunity is a major supplier of AI accelerators, CPUs and network processors. After completing a benchmark evaluation, that customer agreed to purchase a fully configured FOX-XP wafer-level burn-in test cell for installation at an OSAT partner in Taiwan. Installation is planned for early calendar 2027, with a high-volume production decision expected within several months after validation.

Management characterized the opportunity as one of the largest it has pursued, citing the potential to deploy burn-in systems across multiple products and manufacturing sites. However, it remains an evaluation program rather than a production award. Its economic value will depend on the system’s performance in a high-volume environment and the customer’s eventual capacity plans.

Aehr also reported additional production orders for silicon-photonics applications and said silicon carbide utilization and WaferPak orders are improving. Silicon carbide represented less than 10% of fiscal 2026 revenue, according to management, after having been a much larger contributor in earlier years. The company said it has already received a $7M silicon-carbide order and expects the market to contribute more in fiscal 2027.

Memory remains a longer-dated opportunity. Management said NAND-related opportunities are progressing more slowly than expected because of limited incremental manufacturing capacity and the timing of new high-bandwidth flash architectures. It also sees potential demand from high-bandwidth memory base dies, but those programs remain developmental.

What is Aehr Test Systems’ guidance for fiscal 2027?

Aehr raised its fiscal 2027 revenue outlook to $150M, compared with previous guidance of $130M to $150M. The revised target implies 200% growth over fiscal 2026 revenue.

Management also expects non-GAAP net income of at least 20% of revenue for the year. The outlook is supported by existing backlog, production ramps at current customers and expected delivery schedules.

Management indicated that revenue should increase through the remaining quarters of fiscal 2027, with the fourth quarter potentially the largest. It also said the $150M target is not currently constrained by manufacturing capacity, although customer ordering patterns and requested delivery dates remain important variables.

Balance Sheet, Cash Flow and Capital

Aehr ended the quarter with $105.1M of cash, cash equivalents and restricted cash and no debt. Cash declined from $116.5M at the end of fiscal 2026.

Operating cash flow was negative $3.1M despite positive net income. The principal use of cash was working capital: accounts receivable increased by $10.7M and inventory rose by $9.0M. Management said it is purchasing long-lead-time components to support anticipated AI-related production demand and reduce supply-chain risk.

Capital expenditures were modest at $49,000 during the quarter. The manufacturing expansion in Southeast Asia relies on a contract manufacturer, allowing Aehr to add Sonoma capacity without a comparable increase in infrastructure spending.

What Investors Should Watch

1. Conversion of the Taiwan wafer-level evaluation

The planned early-calendar-2027 installation for the major AI processor customer is the clearest potential step-up in Aehr’s future revenue opportunity. A production decision after validation would support management’s claim that wafer-level burn-in can move beyond isolated programs into broader AI processor deployments.

2. Execution of the hyperscale Sonoma ramp

Aehr is shipping more than a dozen Sonoma systems per month to its lead hyperscale customer. Investors should watch whether that pace is sustained and whether the second AI processor transitions from sampling to the anticipated 2027 production ramp.

3. Backlog conversion and booking quality

The $100.9M backlog provides substantial support for the $150M revenue target, but effective backlog includes $8.4M of orders received after quarter-end. Continued bookings above revenue would provide greater visibility beyond fiscal 2027, while lower booking activity could increase dependence on existing schedules.

4. Consumables mix

Consumables and related products accounted for 41% of first-quarter revenue. Maintaining a sizable contribution from WaferPaks, burn-in modules and related products would indicate that system deployments are translating into ongoing production demand rather than one-time equipment sales.

5. Working-capital discipline

Inventory and receivables increased sharply as Aehr prepared for larger deliveries. That investment may support growth, but operating cash flow will be an important test of whether higher revenue converts into cash as production programs mature.

AlgovestIQ Takeaway

Aehr’s first quarter was materially stronger than the comparable prior-year period. Revenue reached a record $33.0M, margins expanded, the company returned to GAAP profitability, and bookings exceeded revenue. The higher fiscal 2027 revenue target is backed by a backlog that has grown above $100M and by visible shipment activity for existing AI programs.

The improved revenue mix is also notable. Consumables and related products represented 41% of sales, showing that production activity at existing customers is contributing alongside system shipments. That can make Aehr’s revenue base more durable over time, although consumables remain tied to customer volume and device-transition cycles.

The unresolved question is how quickly prospective AI wafer-level burn-in programs become production deployments. The Taiwan evaluation with a major AI processor supplier could materially expand Aehr’s addressable revenue base, but it is not yet a high-volume order. Management’s description of the opportunity is encouraging, but the investment case still depends on validation, customer capacity decisions and execution at an OSAT production site.

Evidence that would strengthen the thesis includes sustained Sonoma shipments, continued backlog growth, rising consumables demand and a successful conversion of the Taiwan evaluation into a production award. Conversely, delays in customer ramps, lower utilization in end markets such as silicon carbide, or continued working-capital pressure would temper the significance of the company’s strong opening quarter.

How did AEHR stock react?

AEHR closed at $65.11 on Nov 3, 2026, up 26.5% from $51.47 on Nov 2, 2026, the last close before the results were released.

SessionCloseChange
Nov 2, 2026 (before release)$51.47—
Nov 3, 2026$65.11+26.5%

Closing prices from AlgovestIQ market data. A move around a report also reflects the wider market.

More from this earnings season

References

  1. Management commentary, analyst questions and outlook discussed on the call. Source: Aehr Test Systems Q1 FY2027 earnings call transcript, as of Nov 2, 2026.
  2. Reported results, segment figures and guidance from the company's results announcement. Source: Aehr Test Systems Form 8-K, Item 2.02 (SEC EDGAR), as of Nov 2, 2026.
  3. Reported revenue and EPS against analyst estimates, and the reported quarterly series. Source: AlgovestIQ reported-results data, as of Nov 2, 2026.

AI-generated analysis based on company-reported earnings data and earnings-call materials. Not investment advice.